Ariad Going to Hell in a Handbasket
ThinkstockThings just keep getting worse for Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). In fact, a series of shareholder revolts are probably in the works here after yet another massive drop on news that it is…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 300Teva Pharmaceutical Shares Plunge on CEO Resignation
ThinkstockAfter denying rumors earlier this week that its CEO was considering resigning, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Wednesday morning that President and Chief Executive Jeremy Levin indeed will depart from the company.…
Pfizer Continues to Shrink
Wikimedia CommonsPfizer Inc. (NYSE: PFE) reported third-quarter 2013 results before markets opened Tuesday morning. The drug maker posted adjusted diluted earnings per share (EPS) of $0.58 and revenues of $12.64 billion. In the same…
Merck Sets Low Earnings Bar for Pfizer
The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this week are Dow Jones Industrial Average components. Merck & Co. (NYSE: MRK) reported earnings on…
Four Companies That Easily Could Run the Healthcare.gov Sign-Up Process
Healthcare.govSince the passage of the Affordable Care Act, or Obamacare, the launch has been riddled with problems. Accessing the sign-up page, poor Web design, untested and inept technology, and endless attacks on how the…
Merck Continues to Face Revenue Challenges
ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted adjusted diluted earnings per share (EPS) of $0.92 and revenues of $11.03 billion. In…
eHealth Wins as Obamacare Technology Flop Persists
ThinkstockIt is not uncommon that a loss of business at one provider is a win for other providers. If you have followed the Healthcare.gov list of continual sign-up issues since the start of the…
pSivida, Alimera and Ariad Join Bio-Implosion Watch
ThinkstockBiotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn exponential rewards if they are right, or they can lose it all if they…
UnitedHealth Earnings OK, Outlook Disappoints
ThinkstockUnitedHealth Group Inc. (NYSE: UNH) reported third-quarter 2013 results before markets opened Thursday morning. The health insurance and benefits management firm posted diluted quarterly earnings per share (EPS) of $1.53 on revenues of $30.6…
Amarin Implosion: The Future Went from Promising to Doubtful
ThinkstockBiotech is a sector where investors know they are entering a high-stakes game of big risk and big reward. That is particularly the case for the small-cap biotech stocks that have no products and…
Oreos Are as Addictive as Cocaine
ThinkstockSome good news for makers of cookies and candy. Recent research shows that Oreos are as addictive as cocaine. However, the companies may want to hold off celebrating. The data are based on the habits of…
Johnson & Johnson Growth Stalls
Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported third-quarter 2013 results before markets opened Tuesday morning. The health care giant posted quarterly adjusted diluted earnings per share (EPS) of $1.36 on revenue of $17.58 billion.…
Is Inhalable Insulin Assured To Be Approved By The FDA?
ThinkstockIf you have followed the diabetes drug market for very long, chances are high that you have run across the possibility of an inhalable form of insulin ultimately being approved by the Food &…
Coronado Implodes over Crohn’s Failure, Future Now Uncertain
Investing in biotech and emerging pharmaceutical stocks comes with a huge risk and reward profile for investors. Some wins are exponential, yet some losses are losses of the entire investment. Coronado Biosciences Inc. (NASDAQ:…
Jefferies Top Biotech Stocks to Buy
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated does. That…